Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
359.5000 -2.80 (-0.77%)
NSE Oct 24, 2025 15:31 PM
Volume: 1.0M
 

logo
Biocon Ltd.
02 Nov 2020
359.50
-0.77%
Axis Direct
Biocon Ltd is an integrated biotechnology enterprise with a presence in biopharmaceuticals, enzymes, custom research and clinical research. The Company's pharmaceutical products include statins, immune suppressants and anti-diabetic drugs.
Biocon Ltd. has an average target of 354.40 from 5 brokers.
More from Biocon Ltd.
Recommended